Bioelectronics Corp Stock Technical Analysis

BIEL Stock  USD 0.0003  0.0001  25.00%   
As of the 30th of January, Bioelectronics Corp shows the Downside Deviation of 25.62, risk adjusted performance of 0.0495, and Mean Deviation of 12.98. Bioelectronics Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bioelectronics Corp jensen alpha, as well as the relationship between the potential upside and skewness to decide if Bioelectronics Corp is priced correctly, providing market reflects its regular price of 3.0E-4 per share. As Bioelectronics Corp appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Bioelectronics Corp Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bioelectronics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Bioelectronics
  
Bioelectronics Corp's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
It's important to distinguish between Bioelectronics Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bioelectronics Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Bioelectronics Corp's market price signifies the transaction level at which participants voluntarily complete trades.

Bioelectronics Corp 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioelectronics Corp's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioelectronics Corp.
0.00
11/01/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/30/2026
0.00
If you would invest  0.00  in Bioelectronics Corp on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Bioelectronics Corp or generate 0.0% return on investment in Bioelectronics Corp over 90 days. BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation... More

Bioelectronics Corp Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioelectronics Corp's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioelectronics Corp upside and downside potential and time the market with a certain degree of confidence.

Bioelectronics Corp Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioelectronics Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioelectronics Corp's standard deviation. In reality, there are many statistical measures that can use Bioelectronics Corp historical prices to predict the future Bioelectronics Corp's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioelectronics Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000318.36
Details
Intrinsic
Valuation
LowRealHigh
0.000.000318.36
Details
Naive
Forecast
LowNextHigh
0.0000070.000318.36
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00030.00030.0003
Details

Bioelectronics Corp January 30, 2026 Technical Indicators

Bioelectronics Corp Backtested Returns

Bioelectronics Corp appears to be out of control, given 3 months investment horizon. Bioelectronics Corp secures Sharpe Ratio (or Efficiency) of 0.042, which signifies that the company had a 0.042 % return per unit of risk over the last 3 months. By analyzing Bioelectronics Corp's technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please makes use of Bioelectronics Corp's Downside Deviation of 25.62, mean deviation of 12.98, and Risk Adjusted Performance of 0.0495 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bioelectronics Corp holds a performance score of 3. The firm shows a Beta (market volatility) of 7.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bioelectronics Corp will likely underperform. Please check Bioelectronics Corp's sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Bioelectronics Corp's price patterns will revert.

Auto-correlation

    
  0.21  

Weak predictability

Bioelectronics Corp has weak predictability. Overlapping area represents the amount of predictability between Bioelectronics Corp time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioelectronics Corp price movement. The serial correlation of 0.21 indicates that over 21.0% of current Bioelectronics Corp price fluctuation can be explain by its past prices.
Correlation Coefficient0.21
Spearman Rank Test0.22
Residual Average0.0
Price Variance0.0
Bioelectronics Corp technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Bioelectronics Corp technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bioelectronics Corp trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Bioelectronics Corp Technical Analysis

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Bioelectronics Corp volatility developed by Welles Wilder.

About Bioelectronics Corp Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bioelectronics Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bioelectronics Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bioelectronics Corp price pattern first instead of the macroeconomic environment surrounding Bioelectronics Corp. By analyzing Bioelectronics Corp's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bioelectronics Corp's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bioelectronics Corp specific price patterns or momentum indicators. Please read more on our technical analysis page.

Bioelectronics Corp January 30, 2026 Technical Indicators

Most technical analysis of Bioelectronics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bioelectronics from various momentum indicators to cycle indicators. When you analyze Bioelectronics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Bioelectronics Corp January 30, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bioelectronics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Other Information on Investing in Bioelectronics Pink Sheet

Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.